T cell recognition and immunity in the fetus and mother

Cellular Immunology

Volumn 248, Issue 1, 2007, Pages 12-17

  Koch, Cody A ^a,b   Platt, Jeffrey L ^a,b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Anergy; Chimerism; Fetus; Indoleamine 2,3 diosygenase; Non classical MHC; Pregnancy; Tolerance; Tryptophan

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FETAL ANTIGEN; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD PLACENTA BARRIER; CELL INVASION; CELL PROTECTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CHIMERA; CLONAL ANERGY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RELIABILITY; REPRODUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD95; CYTOKINES; EXTRAEMBRYONIC MEMBRANES; FAS LIGAND PROTEIN; FEMALE; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, MATERNALLY-ACQUIRED; ISOANTIGENS; LYMPHOCYTES; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; TRYPTOPHAN;

EUTHERIA; MAMMALIA;

EID: 36048968893     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.05.006     Document Type: Article

References (54)

1. Ogle B.M., Cascalho M., and Platt J.L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 6 (2005) 567-575
2. Medawar P.B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7 (1954) 320-338
3. Koch C.A., and Platt J.L. Natural mechanisms for evading graft rejection: the fetus as an allograft. Springer Semin. Immunopathol. 25 (2003) 95-117
4. Woodruff M.F.A. Transplantation immunity and the immunological problem of pregnancy. Proc. R. Soc. Lond. 148 (1958) 68-85
5. Beer A.E., and Billingham R.E. Implantation, transplantation, and epithelial-mesenchymal relationships in the rat uterus. J. Exp. Med. 132 (1970) 721-736
6. Tallon D.F., Corcoran D.J., O'Dwyer E.M., and Greally J.F. Circulating lymphocyte subpopulations in pregnancy: a longitudinal study. J. Immunol. 132 (1984) 1784-1787
7. Watanabe M., Iwatani Y., Kaneda T., Hidaka Y., Mitsuda N., Morimoto Y., and Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am. J. Reprod. Immunol. 37 (1997) 368-377
8. Vacchio M.S., and Jiang S.P. The fetus and the maternal immune system: pregnancy as a model to study peripheral T-cell tolerance. Crit. Rev. Immunol. 19 (1999) 461-480
9. Carter J., Newport A., Keeler K.D., and Dresser D.W. FACS analysis of changes in T and B lymphocyte populations in the blood, spleen and lymph nodes of pregnant mice. Immunology 48 (1983) 791-797
10. Tafuri A., Alferink J., Moller P., Hammerling G.J., and Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 270 (1995) 630-633
11. + T-cells specific for paternal MHC class I accumulate during pregnancy. J. Reprod. Immunol. 40 (1998) 47-62
12. Jiang S.P., and Vacchio M.S. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J. Immunol. 160 (1998) 3086-3090
13. Zuckermann F.A., and Head J.R. Possible mechanism of non-rejection of the feto-placental allograft: trophoblast resistance to lysis by cellular immune effectors. Transplant. Proc. 19 (1987) 554-556
14. Redline R.W. The structural basis of maternal-fetal immune interactions in the human placenta. Curr. Top. Microbiol. Immunol. 222 (1997) 25-44
15. Thomas M.R., Tutschek B., Frost A., Rodeck C.H., Yazdani N., Craft I., and Williamson R. The time of appearance and disappearance of fetal DNA from the maternal circulation. Prenat. Diagn. 15 (1995) 641-646
16. Lo Y.M., Lo E.S., Watson N., Noakes L., Sargent I.L., Thilaganathan B., and Wainscoat J.S. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88 (1996) 4390-4395
17. Walknowska J., Conte F.A., and Grumbach M.M. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1 (1969) 1119-1122
18. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., and DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl. Acad. Sci. USA 93 (1996) 705-708
19. Srivatsa B., Srivatsa S., Johnson K.L., Samura O., Lee S.L., and Bianchi D.W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358 (2001) 2034-2038
20. Sykes M. Mixed chimerism and transplant tolerance. Immunity 14 (2001) 417-424
21. Redline R.W., and Lu C.Y. Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship. Lab. Invest. 61 (1989) 27-36
22. Redman C.W., McMichael A.J., Stirrat G.M., Sunderland C.A., and Ting A. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. Immunology 52 (1984) 457-468
23. Shomer B., Toder V., Egorov I., and Ehrlich R. Expression of allogeneic MHC class I antigens by transgenic mouse trophoblast does not interfere with the normal course of pregnancy. Transgenic Res. 7 (1998) 343-355
24. Rogers A.M., Boime I., Connolly J., Cook J.R., and Russell J.H. Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand. Eur. J. Immunol. 28 (1998) 3479-3487
25. Adachi M., Suematsu S., Suda T., Watanabe D., Fukuyama H., Ogasawara J., Tanaka T., Yoshida N., and Nagata S. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93 (1996) 2131-2136
26. Green D.R., and Ferguson T.A. The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol. 2 (2001) 917-924
27. Smith S.C., Leung T.N., To K.F., and Baker P.N. Apoptosis is a rare event in first-trimester placental tissue. Am. J. Obstet. Gynecol. 183 (2000) 697-699
28. Jerzak M., Kasprzycka M., Wierbicki P., Kotarski J., and Gorski A. Apoptosis of T cells in the first trimester human decidua. Am. J. Reprod. Immunol. 40 (1998) 130-135
29. Jerzak M., and Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling. Eur. J. Obstet. Gynecol. Reprod. Biol. 100 (2002) 138-142
30. Hunt J.S., Vassmer D., Ferguson T.A., and Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the concepts. J. Immunol. 158 (1997) 4122-4128
31. Bamberger A.M., Schulte H.M., Thuneke I., Erdmann I., Bamberger C.M., and Asa S.L. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J. Clin. Endocrinol. Metab. 82 (1997) 3173-3175
32. Coumans B., Thellin O., Zorzi W., Melot F., Bougoussa M., Melen L., Zorzi D., Hennen G., Igout A., and Heinen E. Lymphoid cell apoptosis induced by trophoblastic cells: a model of active foeto-placental tolerance. J. Immunol. Methods 224 (1999) 185-196
33. Vacchio M.S., and Hodes R.J. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J. Immunol. 174 (2005) 4657-4661
34. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism. Science 281 (1998) 1191-1193
35. Schrocksnadel H., Baier-Bitterlich G., Dapunt O., Wachter H., and Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 88 (1996) 47-50
36. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., and Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189 (1999) 1363-1372
37. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., and Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196 (2002) 447-457
38. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196 (2002) 459-468
39. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., Fioretti M.C., and Puccetti P. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9 (2002) 1069-1077
40. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., and Carosella E.D. HLA-G inhibits the allogeneic proliferative response. J. Reprod. Immunol. 43 (1999) 203-211
41. Kapasi K., Albert S.E., Yie S., Zavazava N., and Librach C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101 (2000) 191-200
42. + cells by interacting with CD8. J. Immunol. 164 (2000) 6100-6104
43. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin. Immunol. 13 (2001) 219-227
44. Mellor A.L., and Munn D.H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18 (2000) 367-391
45. Chaouat G., Assal Meliani A., Martal J., Raghupathy R., Elliot J., Mosmann T., and Wegmann T.G. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J. Immunol. 154 (1995) 4261-4268
46. + T cell-dependent suppression of natural effector cell cytotoxicity against trophoblast target cells. Cell Immunol. 154 (1994) 143-152
47. Hill J.A., Polgar K., and Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273 (1995) 1933-1936
48. Guleria I., Khosroshahi A., Ansari M.J., Habicht A., Azuma M., Yagita H., Noelle R.J., Coyle A., Mellor A.L., Khoury S.J., and Sayegh M.H. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202 (2005) 231-237
49. Chaouat G., Voisin G.A., Daeron M., and Kanellopoulos J. Enhancing antibodies and suppressive cells in maternal anti-fetal immune reaction. Ann. Immunol. (Paris) 128 (1977) 21-24
50. Chaouat G., and Voisin G.A. Regulatory T cell subpopulations in pregnancy. I. Evidence for suppressive activity of the early phase of MLR. J. Immunol. 122 (1979) 1383-1388
51. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
52. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5 (2004) 266-271
53. + regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol. Lett. 102 (2006) 106-109
54. Zenclussen A.C., Gerlof K., Zenclussen M.L., Ritschel S., Zambon Bertoja A., Fest S., Hontsu S., Ueha S., Matsushima K., Leber J., and Volk H.D. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur. J. Immunol. 36 (2006) 82-94